Literature DB >> 15997179

[A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis].

Shoko Nakajima1, Hiroaki Umebayashi, Rumiko Kurosawa, Tomoyuki Imagawa, Shigeki Katakura, Masaaki Mori, Yuko Aihara, Shumpei Yokota, Tuyoshi Sogo, Ayano Inui, Tomoo Fujisawa, Norio Hanzawa.   

Abstract

A 10-year-old girl with autoimmune hepatitis (AIH) was reported. She was admitted to our hospital because of cholestasis and elevation of liver enzymes for 2 months. Laboratory examination revealed that EBV-DNA copy number in the PBMNC (peripheral mononuclear cells) was 1.2 x 10(3) copies/microg of DNA, hypergammaglobulinemia, and positive antinuclear antibody, positive anti-smooth muscle antibody. The histology of her liver biopsy specimen revealed interface hepatitis, dense mononuclear cell infiltrates, mild fibrosis, and negative for EBV in situ hybridization assay indicating AIH and not EBV-associated hepatitis. She was treated firstly with methylprednisolone pulses, then will prednisolone p.o.+azathioprine p.o.. Intravenous cyclophosphamide pulse therapy was introduced because of her abnormal immune pathology. All abnormal laboratory parameters improved to normal levels within 2 months, and EBV-DNA copy number in the PBMNC became negative after 4 months. The histology of liver biopsy specimen was useful for the diagnosis of AIH in such a difficult case needed to be differentiated from EBV hepatitis.

Entities:  

Mesh:

Year:  2005        PMID: 15997179     DOI: 10.2177/jsci.28.154

Source DB:  PubMed          Journal:  Nihon Rinsho Meneki Gakkai Kaishi        ISSN: 0911-4300


  3 in total

1.  Autoimmune hepatitis following Epstein-Barr virus infection.

Authors:  Daniela Cabibi
Journal:  BMJ Case Rep       Date:  2008-11-20

2.  Chronic Active Epstein-Barr Virus Infection Indistinguishable from Autoimmune Hepatitis: A Case Report.

Authors:  Suguru Ikeda; Takaaki Sugihara; Takuya Kihara; Yoshiki Hoshino; Yukako Matsuki; Takakazu Nagahara; Kenji Oyama; Jun-Ichi Okano; Satoshi Kuwamoto; Yasushi Horie; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2022-04-13       Impact factor: 1.371

3.  Epstein-barr virus as a trigger of autoimmune liver diseases.

Authors:  Eirini I Rigopoulou; Daniel S Smyk; Claire E Matthews; Charalambos Billinis; Andrew K Burroughs; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Adv Virol       Date:  2012-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.